{"log_id": 853012480446479632, "direction": 0, "words_result_num": 43, "words_result": [{"probability": {"variance": 0, "average": 0.935768, "min": 0.935768}, "location": {"width": 58, "top": 145, "height": 20, "left": 798}, "words": " HKICN"}, {"probability": {"variance": 0.000211, "average": 0.996221, "min": 0.905105}, "location": {"width": 879, "top": 206, "height": 78, "left": 181}, "words": "剂量可增加至100mg,每天一次。为达到目标血压,必要时可添加其它抗高血压药物进行治疗"}, {"probability": {"variance": 0.005359, "average": 0.986015, "min": 0.517892}, "location": {"width": 873, "top": 250, "height": 73, "left": 186}, "words": "(如增加氢氯噻嗪的剂量至25mg,或添加其它利尿剂、钙通道阻滞剂、a受体阻滞剂,或中"}, {"probability": {"variance": 0.000177, "average": 0.99519, "min": 0.922189}, "location": {"width": 768, "top": 296, "height": 70, "left": 175}, "words": "枢作用药物,但不能添加ACE抑制剂、血管紧张素II受体拮抗剂或受体阻滞剂)"}, {"probability": {"variance": 0.000327, "average": 0.996449, "min": 0.885154}, "location": {"width": 845, "top": 333, "height": 72, "left": 219}, "words": "两个治疗组的血压均显著降低到近似水平,并且相似比例患者的血压均降到理想水平。平"}, {"probability": {"variance": 0.000268, "average": 0.99382, "min": 0.94477}, "location": {"width": 197, "top": 411, "height": 36, "left": 178}, "words": "均随访时间是4.8年"}, {"probability": {"variance": 6e-06, "average": 0.998758, "min": 0.989625}, "location": {"width": 841, "top": 417, "height": 70, "left": 224}, "words": "首要临床终点为心血管患病率和死亡率,其观察指标为心血管死亡、中风和心肌梗死综合"}, {"probability": {"variance": 1.2e-05, "average": 0.997957, "min": 0.982465}, "location": {"width": 887, "top": 457, "height": 75, "left": 182}, "words": "发生率的下降。结果显示,与阿替洛尔组相比,氯沙坦组首要综合终点的危险性下降13%"}, {"probability": {"variance": 0.001909, "average": 0.982384, "min": 0.835321}, "location": {"width": 187, "top": 536, "height": 30, "left": 188}, "words": "(=0.021)(见图1)"}, {"probability": {"variance": 0, "average": 0.998917, "min": 0.998649}, "location": {"width": 52, "top": 760, "height": 24, "left": 366}, "words": "者首"}, {"probability": {"variance": 1e-06, "average": 0.998299, "min": 0.997285}, "location": {"width": 50, "top": 778, "height": 23, "left": 367}, "words": "比次"}, {"probability": {"variance": 0, "average": 0.998929, "min": 0.998929}, "location": {"width": 25, "top": 803, "height": 21, "left": 366}, "words": "例"}, {"probability": {"variance": 0, "average": 0.999375, "min": 0.999375}, "location": {"width": 23, "top": 797, "height": 20, "left": 395}, "words": "发"}, {"probability": {"variance": 0, "average": 0.999177, "min": 0.999177}, "location": {"width": 23, "top": 818, "height": 21, "left": 395}, "words": "生"}, {"probability": {"variance": 0, "average": 0.999871, "min": 0.999745}, "location": {"width": 50, "top": 839, "height": 26, "left": 370}, "words": "%时"}, {"probability": {"variance": 0, "average": 0.999578, "min": 0.999578}, "location": {"width": 22, "top": 862, "height": 20, "left": 398}, "words": "间"}, {"probability": {"variance": 4e-06, "average": 0.997982, "min": 0.996005}, "location": {"width": 18, "top": 853, "height": 19, "left": 755}, "words": "0%"}, {"probability": {"variance": 0.01317, "average": 0.954455, "min": 0.572044}, "location": {"width": 287, "top": 842, "height": 29, "left": 902}, "words": "校正后危险性下降:13%,p=0.02"}, {"probability": {"variance": 0, "average": 0.999619, "min": 0.999619}, "location": {"width": 25, "top": 882, "height": 21, "left": 396}, "words": "的"}, {"probability": {"variance": 0, "average": 0.999929, "min": 0.999929}, "location": {"width": 23, "top": 903, "height": 21, "left": 400}, "words": "患"}, {"probability": {"variance": 8.7e-05, "average": 0.993752, "min": 0.9611}, "location": {"width": 236, "top": 893, "height": 28, "left": 560}, "words": "121824303642485460"}, {"probability": {"variance": 1e-06, "average": 0.998066, "min": 0.996634}, "location": {"width": 94, "top": 895, "height": 25, "left": 905}, "words": "时间(月)"}, {"probability": {"variance": 0.008934, "average": 0.982839, "min": 0.380259}, "location": {"width": 885, "top": 934, "height": 69, "left": 202}, "words": "图1.在氯沙坦和阿替洛尔治疗组,对基线时弗明翰危险因素评分及心电图LH程度校正后的"}, {"probability": {"variance": 0.001559, "average": 0.987888, "min": 0.814678}, "location": {"width": 636, "top": 986, "height": 59, "left": 204}, "words": "心血管死亡、中风或心肌梗死的首要综合终点的 Kaplan- Meier曲线"}, {"probability": {"variance": 7e-06, "average": 0.998335, "min": 0.990118}, "location": {"width": 544, "top": 1071, "height": 52, "left": 249}, "words": "与阿替洛尔组相比,氯沙坦治疗组降低中风的危险性达25"}, {"probability": {"variance": 7.2e-05, "average": 0.993968, "min": 0.969655}, "location": {"width": 229, "top": 1060, "height": 30, "left": 844}, "words": "0001)。这两个组在降"}, {"probability": {"variance": 3e-06, "average": 0.998777, "min": 0.991521}, "location": {"width": 882, "top": 1097, "height": 71, "left": 209}, "words": "低心血管死亡和心肌梗死方面没有显著差别。在降低首要综合终点发生率方面,氯沙坦显示出"}, {"probability": {"variance": 1.6e-05, "average": 0.998185, "min": 0.982862}, "location": {"width": 338, "top": 1165, "height": 44, "left": 210}, "words": "超越血压控制方面的益处(见下表)"}, {"probability": {"variance": 0.076776, "average": 0.797592, "min": 0.405792}, "location": {"width": 139, "top": 1150, "height": 71, "left": 1015}, "words": "药有"}, {"probability": {"variance": 0.000799, "average": 0.983065, "min": 0.90389}, "location": {"width": 190, "top": 1238, "height": 30, "left": 628}, "words": "LIFE研究临床终点"}, {"probability": {"variance": 0, "average": 0.9996, "min": 0.998872}, "location": {"width": 70, "top": 1281, "height": 26, "left": 734}, "words": "阿替尔"}, {"probability": {"variance": 0.023654, "average": 0.839553, "min": 0.481991}, "location": {"width": 386, "top": 1308, "height": 40, "left": 423}, "words": "氯沙坦(N4605)比例458"}, {"probability": {"variance": 0.001709, "average": 0.973355, "min": 0.881322}, "location": {"width": 220, "top": 1292, "height": 32, "left": 837}, "words": "比例*降低危险性*"}, {"probability": {"variance": 0, "average": 0.993432, "min": 0.993432}, "location": {"width": 50, "top": 1279, "height": 35, "left": 1117}, "words": "值"}, {"probability": {"variance": 0, "average": 0.999571, "min": 0.999216}, "location": {"width": 47, "top": 1327, "height": 25, "left": 216}, "words": "结果"}, {"probability": {"variance": 0.00038, "average": 0.97343, "min": 0.952592}, "location": {"width": 23, "top": 1380, "height": 21, "left": 508}, "words": "(%)"}, {"probability": {"variance": 0.00036, "average": 0.962629, "min": 0.943664}, "location": {"width": 31, "top": 1442, "height": 31, "left": 988}, "words": "1%"}, {"probability": {"variance": 0.000677, "average": 0.97277, "min": 0.946747}, "location": {"width": 23, "top": 1440, "height": 23, "left": 1126}, "words": "02"}, {"probability": {"variance": 3e-06, "average": 0.997911, "min": 0.994277}, "location": {"width": 137, "top": 1470, "height": 33, "left": 221}, "words": "首要综合终点"}, {"probability": {"variance": 0.000691, "average": 0.978288, "min": 0.932698}, "location": {"width": 99, "top": 1461, "height": 30, "left": 475}, "words": "508(11%)"}, {"probability": {"variance": 2.6e-05, "average": 0.996267, "min": 0.982157}, "location": {"width": 246, "top": 1446, "height": 38, "left": 652}, "words": "23.8588(13%)27.9"}, {"probability": {"variance": 2e-06, "average": 0.998644, "min": 0.995813}, "location": {"width": 224, "top": 1481, "height": 74, "left": 978}, "words": "杭州默沙东"}, {"probability": {"variance": 0.034973, "average": 0.8751, "min": 0.470708}, "location": {"width": 172, "top": 1527, "height": 45, "left": 1031}, "words": "制药有限公可/3"}], "language": 3}